Investing.com - Sol Gel Tech reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Sol Gel Tech announced earnings per share of $-0.15 on revenue of $261K. Analysts polled by Investing.com anticipated EPS of $-0.07 on revenue of $3.45M.
Sol Gel Tech shares are down 16.92% from the beginning of the year, still down 47.29% from its 52 week high of $9.41 set on November 11, 2021.
Sol Gel Tech shares gained 2.14% in intra-day trade following the report.
Sol Gel Tech follows other major Healthcare sector earnings this month
Sol Gel Tech's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar